The large majority of the report, including:
Section I: AI for Drug Discovery Landscape Overview (Industry Developments Q2 2018),
Section II: Novel Technologies & Trends (Industry Forecast 2019-2020), and Appendices (which feature profiles of 100 Companies, 220 Investors, 15 Biopharma, 15 IT/Tech Corporations, and 20 leading R&D Centres active in the AI for Drug Discovery space) totalling 400 pages in length, has been made available free of charge.
Section III: Comparative Industry Analysis & Classification Framework
(Investor and M&A Guide), 70 pages in length,
specifically tuned to industry professionals such as investors, analysts, BioPharma/Tech executives and decision-makers, is available for purchase.
This section is devoted to an in-depth comparative and quantitative analysis of the entire AI for Drug Discovery landscape, utilizing advanced infographics and tangible parameters.